These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8907803)

  • 1. Effect of repeated administration of KT3-671, a nonpeptide AT1 receptor antagonist, on diurnal variation in blood pressure, heart rate, and locomotor activity in stroke-prone spontaneously hypertensive rats as determined by radiotelemetry.
    Kawashima K; Amano H; Fujimoto K; Suzuki T; Fujii T; Mochizuki S; Tomiyama A
    J Cardiovasc Pharmacol; 1996 Mar; 27(3):411-6. PubMed ID: 8907803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effect of repeatedly administered YM358, an angiotensin AT1-receptor antagonist, in stroke-prone spontaneously hypertensive rats.
    Yamaguchi N; Fujimoto K; Fujii T; Suzuki T; Kawashima K
    Jpn J Pharmacol; 1997 Jan; 73(1):83-91. PubMed ID: 9032137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effect of chronic KT3-671, a structurally new nonpeptide angiotensin AT1-receptor antagonist, in stroke-prone spontaneously hypertensive rats.
    Amano H; Fujimoto K; Suzuki T; Fujii T; Mochizuki S; Tomiyama A; Kawashima K
    Jpn J Pharmacol; 1995 Nov; 69(3):215-22. PubMed ID: 8699629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological properties of KT3-671, a novel nonpeptide angiotensin II receptor antagonist.
    Mochizuki S; Sato T; Furuta K; Hase K; Ohkura Y; Fukai C; Kosakai K; Wakabayashi S; Tomiyama A
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):22-9. PubMed ID: 7723348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KT3-671, an angiotensin AT1 receptor antagonist, attenuates vascular but not cardiac responses to sympathetic nerve stimulation in pithed rats.
    Takata Y; Kurihara J; Yoda T; Suzuki S; Matsuoka Y; Okubo Y; Kato H
    J Cardiovasc Pharmacol; 2001 Apr; 37(4):427-36. PubMed ID: 11300656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of circadian blood pressure rhythm and target-organ damage in stroke-prone spontaneously hypertensive rats.
    Shimamura T; Nakajima M; Iwasaki T; Hayasaki Y; Yonetani Y; Iwaki K
    J Hypertens; 1999 Feb; 17(2):211-20. PubMed ID: 10067790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian rhythms of blood pressure, heart rate, and locomotor activity in spontaneously hypertensive rats as measured with radio-telemetry.
    van den Buuse M
    Physiol Behav; 1994 Apr; 55(4):783-7. PubMed ID: 8190809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic effects of central and systemic administration of losartan on blood pressure and baroreceptor reflex in spontaneously hypertensive rats.
    Kawano Y; Yoshida K; Matsuoka H; Omae T
    Am J Hypertens; 1994 Jun; 7(6):536-42. PubMed ID: 7917152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
    Bunting MW; Widdop RE
    Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging but not sodium loading significantly attenuated diurnal change in blood pressure in stroke-prone spontaneously hypertensive rats.
    Zhao B; Kohara K; Hiwada K
    Am J Hypertens; 1999 Sep; 12(9 Pt 1):900-5. PubMed ID: 10509548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II type 1 receptor antagonist and angiotensin-converting enzyme inhibitor altered the activation of Cu/Zn-containing superoxide dismutase in the heart of stroke-prone spontaneously hypertensive rats.
    Tanaka M; Umemoto S; Kawahara S; Kubo M; Itoh S; Umeji K; Matsuzaki M
    Hypertens Res; 2005 Jan; 28(1):67-77. PubMed ID: 15969257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo pharmacologic profile of SK-1080, an orally active nonpeptide AT1-receptor antagonist.
    Lee BH; Seo HW; Kwon KJ; Yoo SE; Shin HS
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):375-82. PubMed ID: 10069671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonist.
    Hilditch A; Hunt AA; Gardner CJ; Twissell DJ; Polley J; Travers A; Drew GM; Middlemiss D; Ross BC; Robertson MJ
    Br J Pharmacol; 1994 Jan; 111(1):137-44. PubMed ID: 8012689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acute and chronic treatment with the angiotensin II subtype 1 receptor antagonist EXP 3174 on baroreflex function in conscious spontaneously hypertensive rats.
    Bartholomeusz B; Widdop RE
    J Hypertens; 1995 Feb; 13(2):219-25. PubMed ID: 7615952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats.
    Schnecko A; Witte K; Lemmer B
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):214-21. PubMed ID: 7475045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AT1 receptor antagonist treatment caused persistent arterial functional changes in young spontaneously hypertensive rats.
    Gillies LK; Lu M; Wang H; Lee RM
    Hypertension; 1997 Dec; 30(6):1471-8. PubMed ID: 9403569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory effect of KT3-671, a nonpeptide angiotensin-receptor antagonist, on rabbit and rat isolate vascular smooth muscles: a possible involvement of K(ATP) channels.
    Satake N; Imanishi M; Keto Y; Ishikawa M; Yamada H; Shibata S; Tomiyama A
    J Cardiovasc Pharmacol; 2000 Mar; 35(3):457-67. PubMed ID: 10710133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats.
    Gohlke P; Linz W; Schölkens BA; Wiemer G; Unger T
    Hypertension; 1996 Sep; 28(3):397-402. PubMed ID: 8794823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats.
    Naruse M; Tanabe A; Sato A; Takagi S; Tsuchiya K; Imaki T; Takano K
    Hypertension; 2002 Jul; 40(1):28-33. PubMed ID: 12105134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive activity and pharmacokinetics of KD3-671, a nonpeptide AT1-receptor antagonist, in renal hypertensive dogs.
    Takata Y; Tajima S; Mochizuki S; Suzaka H; Tomiyama A; Kato H
    J Cardiovasc Pharmacol; 1998 Nov; 32(5):834-44. PubMed ID: 9821859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.